Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 study

Guardado en:
Detalles Bibliográficos
Autores principales: Joseph F Merola, Frank Behrens, Marina Magrey, Liang Chen, Derek Haaland, Koji Kato, Mitsumasa Kishimoto, Patrick Zueger, Aileen L Pangan, Cesar Pacheco-Tena, John Liu, Yuanyuan Duan, Ralph Lippe
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Medicine
R
Acceso en línea:https://doaj.org/article/3246209a50e946a796e8247c73843f2e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares